Proposed Protocol for Investigation of Metabolic Disease in Acutely
Ill Neonates and Young Children
(1st Edition )
Department of Chemical Pathology
The Chinese University of Hong Kong
Faculty of Medicine/Prince of Wales Hospital
Shatin, N.T.
For further advice:
- contact your own laboratory.
- search OMIN (Online Mendelian Inheritance in Man)
an extensive but easily accessible source of information
contact this Department which is happy to assist with further information if required.
Contact Duty Biochemist (Tel: (852) 2632 2331) or on-call Paediatrician thro' Hospital operator (852)2632 2211
Fax:(852) 2636 5090
E-mail: hjelm@cuhk.edu.hk
Please submit suggestions for improvement to Professor Hjelm: hjelm@cuhk.edu.hk
ISSUED BY: PROFESSOR N M HJELM
COS OF CHEMICAL PATHOLOGY
Date: February 1997
Last modified: 7 May, 1997 HKT
You are the
vistors.
Twenty five of the most common inherited metabolic diseases
Link to OMIN (Online Mendelian Inheritance in Man)
The clinical presentation of IMD during neonatal period is usually
of a baby that is getting seriously ill a few days after delivery
and after feeding has started. The best chance to establish the
biochemical characteristics of metabolic disease is at the time
when deterioration occurs. Therefore samples need to be collected
before any therapeutic measures have been instigated.
IMD comprised of heterogeneous groups of entities, thus there
is no single diagnostic feature, however, the following pointers
may be present,
- family history of similar illness in other siblings or cousins,
- family history of unexplained infant death,
- previous episodes of similar illness in the patient,
- previous episodes of unexplained metabolic derangement, e.g.
hypoglycaemia, acidosis, etc.,
- history of change of diet or amount of intake (such as fasting)
before the attack,
- history of abnormal growth or development.
2. Primary investigations
Ensure that the patient is well fed with an adequate protein diet 2-3 hours before carrying out these tests. Neonates should be given a milk feed.
The following screening tests should always be carried out before
any other investigations are considered. Positive results, singly
or in combination, will provide an indication of the presence
of any of twenty five of the most common inherited metabolic diseases
Tests for IMD for immediate analysis.
- Plasma glucose
- Plasma ammonium
- Blood pH and gases
- Urine ketones
- Plasma lactate
- Urine for metabolic screening; reducing substances, glucose,
Tests for IMD for analysis as soon as possible
- Plasma amino acids
- Urine for metabolic screening; organic acids
Tests for other causes of illness for immediate analysis
- Liver and Renal function tests including chloride
Primary investigations for IMD must be carried out as a matter of urgency and if indicated also out of hours.
The specimens should be collected early during the acute episode
before commencing any treatment. (If treatment has been started,
an early post-treatment sample may also be helpful). All specimens should be collected at the same time, even if all analyses are not carried out at the same time. It is essential that the treatment of patients with IMD is instigated without delay in order to avoid irreversible damage to vital organs, especially the brain, and a fatal outcome. The clinical course in neonates and young children can be rapid, and fatal cases have been reported within hours of the initial signs and symptoms of serious illness.
If these simple investigations are normal in a patient that is
well fed the chance of a metabolic disease as the cause of illness
is low.
(A set of tubes should be available for these investigations, see Metabolic Investigation Kit under 5)
Requests should be accompanied by a completed information sheet
for metabolic screening --see sample in appendix 2
| Screening Test | Volume, ml | Container |
| plasma glucose | 0.3 | yellow cap(fluoride tube) |
| plasma ammonium** | 0.75 | orange cap(heparin tube, sent on ice |
| blood gases | 0.3 | heparinised capillary |
| anion gap | | calculated based on routine electrolyte & RFT and blood acid/base results. (Chloride ought to be requested) |
| plasma lactate** | 0.3 | yellow cap(fluoride tube, sent on ice) |
| plasma amino acids | 2 x 0.75 | orange cap (heparin tube) |
| urine for metabolic screening | spot urine* | pink top sterile container |
* 2 ml is optimal but any urine volume can often be used by arrangement with the laboratory.
** Contact the laboratory to arrange for these tests as there are special sample requirements.
Plasma ammonia (in ice), amino acids and blood lactate must be
sent to the laboratory immediately after collection. It is therefore important to contact the laboratory prior to collecting specimens after hours.
Urine specimens can be kept in the ward freezer/refrigerator overnight.
A kit should be prepared containing most of the specimen containers used for metabolic
screening together with an information sheet for metabolic screening.
A simple instruction on the specimen requirements should also be provided.
It is advisable to keep a Metabolic Kit on the paediatric wards for after hours use. This kit should be maintained by the Pathology Laboratory.
It is important that a metabolic screening information sheet as well as the laboratory request form is completed by the clinician.
Suggested contents of the Kit
- 3 x 0.75 ml heparin tubes for L/RFT, chloride and ammonia.
- 2 x 0.3 ml fluoride tube for glucose and lactate.
- 2 x 0.75 ml heparin tubes for plasma amino acid pattern.
- 1 x pink top container for urine collection.
In the event that a patient with suspected inherited metabolic disease
dies before a specific diagnosis can be made, the following procedure
is suggested.
Perimortem collection: Please state the period after death when
the specimen was collection.
(a) Blood collection
- 2 x 5 ml in heparin tube
- 5 ml in EDTA tube
- 2 x 1 ml in fluoride tube
- 10 ml in plain tube (for storage)
(b) Guthrie filter paper for collection of capillary blood.
- Spot
1 to 2 drops of blood onto each of the 4 circles on the right
side until the circles are filled completely on both sides of
the filter paper. Then leave the blood spots to dry in air.
- Blood spots can now be used for the diagnosis of a large number
of inherited metabolic disorders using e.g. mass spectrometry
and DNA-techniques. Locally assays for galactose 1-phosphate
uridyltransferase and carnitine are provided. Other investigations
can be carried out in overseas laboratories on blood spots mailed
to them.
(c) Urine collection
- as much as possible and put in pink top sterile container.
(d) Tissue Collection
Skin (for Fibroblast culture)
- Collect a few core of skin biopsy into sterile container. It
can be kept at 4C refrigerator before being sent for fibroblast
culture.
Liver tissue
- Collect multiple (3-4) cores of liver tissue by perimortem liver
biopsy (preferred) or at early post-mortem dissection.
- Put on aluminium foil, snap freeze and store at -70 C.
Skeletal Muscle tissue
- Put on aluminium foil, snap freeze and store at -70 C.
Bile
- Can be used for post-mortem diagnosis of organic acidaemias.
If any of the screening tests are positive, confirmatory tests need to be carried out. Please contact the
laboratory.
Investigation of metabolic disease
These recommendations are based on:
Hjelm M, Seakins J, Toothill C, Westwood A, Hobbs CA, McMillan
M, Fitzsimmons JS, Pembrey M, Gibbs D, Harkness RA, Green A, Sardharwalla
I, Patrick AD. Proposal for a co-ordinated scheme for the postnatal
diagnosis of inherited metabolic disease in infancy. News Sheet
(Association of Clinical Biochemists) 1983;237:6-12.
General
Green A and Morgan I. Neonatology and Clinical Biochemistry. ACB Venture Publications, 1993
OMIN (Online Mendelian Inheritance in Man)
Go to appendix 1: Test profiles in selected metabolic disorders
Go to appendix 2: Metabolic screening information sheet